Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

National Cancer Center (NCC)

Status: Unknown

Conditions: Breast Cancer

Treatments: Drug: tamoxifen; Behavioral: Decision aids (tamoxifen-related educational materials in brochure or mobile app)

Study type: Interventional

Funder types: Other

Identifiers

NCT02488603

NCCKorea

Details and patient eligibility

About

This is an educational intervention study for breast cancer patients who undergo tamoxifen treatment. The purpose of the study is to assess the impact of decision aids (DA) on the patients' decision-making process, compliance on drug, and knowledge regarding tamoxifen treatment. Patients will randomly assign to DA group or conventional group. Both groups will have baseline questionnaire surveys before starting tamoxifen treatment, and 4 weeks later follow-up questionnaire surveys.

Enrollment: 360 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Breast cancer patients who are recommended to undergo tamoxifen treatment in National Cancer Center, Korea
• • Age at least 18 years and more

Exclusion criteria

• Age under 18 years
• Inability to read or speak Korean
• Disagree to provide a written informed consent

Trial design

360 participants in 2 patient groups

Decision aids

Experimental group

Treatment:

Drug: tamoxifen

Behavioral: Decision aids (tamoxifen-related educational materials in brochure or mobile app)

usual care

No Intervention group